Sad the microdose DMT UK MHRA clinical trial application approvals have taken so long. The pps reflects the delay as does the add-on to the initial prospectus. With these delays in getting approvals and the probable extra documentations needed, AGNPF is still spending to get it done. Sucks to be a long time supporter/shareholder right now. Double down or fold.?. There is this nugget of 'newspeak' I had not seen before implying NASDAQ listing approval....
" We have applied to have our Common Shares listed on the Nasdaq Capital Market under the symbol "AGNP" and recently received approval to list our Common Shares on Nasdaq Capital Market. The successful listing of our Common Shares and Warrants on the Nasdaq Capital Market is a condition of this offering. We do not intend to apply for listing of the Pre-Funded Warrants on the Nasdaq Capital Market."
News 
Market Data 
Discover 
